MIRA INFORM REPORT

 

 

Report No. :

350913

Report Date :

30.11.2015

 

IDENTIFICATION DETAILS

 

Name :

DALAS BIOTECH LIMITED (w.e.f. 12.08.1999)

 

 

Formerly Known As :

SUDMAN LABORATORIES LIMITED (w.e.f. 26.06.1998)

 

AIMIL MEDICAMENTS (INDIA) LIMITED (w.e.f. 11.12.1992)

 

AIMIL MEDICAMENTS (INDIA) PRIVATE LIMITED

 

 

Registered Office :

E-292, Phase – 1, RIICO Industrial Area, Bhiwadi – 301019, Rajasthan

Tel. No.:

91-1493-222123/220125/223478

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

18.07.1989

 

 

Com. Reg. No.:

17-005056

 

 

Capital Investment / Paid-up Capital :

Rs. 44.780 Million

 

 

CIN No.:

[Company Identification No.]

U24232RJ1989PLC005056

 

 

IEC No.:

0598038353

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

JPRD02357F

 

 

PAN No.:

[Permanent Account No.]

AACCS4061Q

 

 

Legal Form :

A Closely Held Public Limited liability Company

 

 

Line of Business :

Manufacturer, Exporter and Importer of Novel Solutions and Intermediates, Bulk, Speciality Drugs etc.

 

 

No. of Employees :

450 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was established in the year 1989 and it is engaged in the manufacturing, exporting and importing of novel solutions and intermediates, bulk drugs and specialty drugs etc.

 

For the financial year ended 2014, company has reported 44.90% sales turnover growth as compared to previous sales turnover but company has failed to maintained profit margins and reported low margins at 0.50% during the year under a review.

 

Rating reflects the extensive experience of company’s promoters in the bulk drugs industry, its established customer profile along with its above average financial risk profile and moderate networth profile.

 

Rating strengths is partially offset by the working-capital-intensive nature of the company’s operations and product concentration in its revenue profile.

 

Trade relations are reported as fair. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: BB+

Rating Explanation

Inadequate-credit-quality and high credit risk.

Date

29.07.2015

 

 

Rating Agency Name

CRISIL

Rating

Short term rating: A4+

Rating Explanation

Minimal degree of safety and very high credit risk.

Date

29.07.2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kamal

Designation :

Account Executive

Contact No.:

91-1493-222527

Date :

24.11.2015

 

 

LOCATIONS

 

Registered Office/ Factory 1:

E-292, Phase – 1, RIICO Industrial Area, Bhiwadi – 301019, Rajasthan, India

Tel. No.:

91-1493-222123/220125/223478

Fax No.:

91-1493-223437

E-Mail :

accounts2@dalasbiotech.com

sales@dalasbiotech.com

info@dalasbiotech.com

Website :

www.dalasbiotech.com

Location :

Owned

Locality :

Commercial

 

 

Factory 2:

SPA-503, RIICO Industrial Area, Bhiwandi – 301019, Alwar, Rajasthan, Inida

Tel. No.:

91-1493-222527, 222537, 222547

Fax No.:

91-1493-221155

E-Mail :

info@dalasbiotech.com

 

 

Head Office :

D-34 , 2nd Floor Gulmohar Park, New Delhi-110049, India

Tel. No.:

91-11-26856191

Fax No.:

91-11-26856218

 

 

 

 

Overseas Office :

7 Fife Road, East Sheen, London SW14 7EJ United Kingdom

Tel. No.:

+44-20-82879972

Fax No.:

+44-20-88766242

 

 

 

 

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Atul Rajani

Designation :

Whole-time director

Address :

D-34, Gulmohar Park, 2nd Floor, New Delhi , India

Date of Birth/Age :

02.02.1978

Date of Appointment :

01.04.2013

DIN No.:

02664208

 

 

Name :

Ms. Lekha Rajani

Designation :

Whole-time director

Address :

D-34, Gulmohar Park, 2nd Floor, New Delhi , India

Date of Birth/Age :

08.01.1946

Date of Appointment :

01.04.2013

DIN No.:

02654340

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232RJ1989PLC005056

DALAS BIOTECH LIMITED

Whole-time director

01/04/2013

31/05/2006

-

Active

NO

2

AAD-8720

LADY ZIGGI SPAUNGE LLP

Designated Partner

05/05/2015

05/05/2015

-

Active

NO

 

 

Name :

Mrrs. Sangita Rajani

Designation :

Director

Address :

D-34, Gulmohar Park, 2nd Floor, New Delhi , India

Date of Appointment :

25.03.2015

DIN No.:

07108694

Other Directorship :

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232RJ1989PLC005056

DALAS BIOTECH LIMITED

Director

25/03/2015

25/03/2015

-

Active

NO

2

AAD-8720

LADY ZIGGI SPAUNGE LLP

Designated Partner

05/05/2015

05/05/2015

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Kamal

Designation :

Account Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Anil Kumar Rajani

 

297329

Deepika Rajani

 

53302

Sangeeta Rajani

 

49668

Lekha Rajani

 

47042

Atul Rajani

 

413

Raj Ram Kumar

 

20

Asha Yogi

 

20

Arjun Dass Lund

 

10

Total

 

447804

 

As on 30.09.2014

 

Category

Percentage

Directors or relatives of Directors

99.99

Other top fifty shareholders

0.01

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of Novel Solutions and Intermediates, Bulk, Speciality Drugs etc.

 

 

Products :

Item Code No. (ITC Code)

Product Description

30032000

Medicaments Containing Other Antibiotics

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Intermediates

Countries :

  • Pakistan
  • China
  • Israel
  • UK
  • UAE

 

 

Imports :

 

Products :

Raw Material

Countries :

  • China
  • Germany
  • Hong Kong

 

 

Terms :

 

Selling :

Cash and Credit (30/60/90 Days)

 

 

Purchasing :

Cash and Credit (30/60/90 Days)

 

 

PRODUCTION STATUS : Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

DDCM Limited, Delhi

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

End Users and OEMs

 

Reference :

Akums Drugs and Pharmaceuticals Limited, Delhi

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

450 (Approximately)

 

 

Bankers :

Banker Name

Oriental Bank of Commerce

Branch Address

Harsha Bhawan, E-Block, Connaught Place, New Delhi - 110001, Delhi, India

Person Name (With Designation)

Not Divulged

Contact Number

91-11-23417254

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Banker Non-Cooperative

 

  • State Bank of Bikaner and Jaipur, Industrial Estate, Bhiwadi – 301019, Rajasthan , India

 

  • Vijaya Bank, DDA Shopping Complex, Defence Colony, Delhi - 110024, India 

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

21.743

51.323

Other loans and advances

3.712

1.340

 

 

 

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

279.440

224.010

Total

304.895

276.673

 

 

 

 

Auditors :

 

Name :

S. Singhal and Company

Chartered Accountants

Address :

E-127, Industrial Area, Bhiwadi – 301019, Rajasthan, India

PAN No.:

AAFFS2873Q

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

900000

Equity Shares

Rs.100/- each

Rs.90.000 Million

100000

Preference Shares

Rs.100/- each

Rs.10.000 Million

 

 

 

 

 

Total

 

Rs.100.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

447804

Equity Shares

Rs.100/- each

Rs.44.780 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

44.780

44.780

44.780

(b) Reserves & Surplus

228.460

219.603

208.270

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

273.240

264.383

253.050

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

30.659

52.667

117.244

(b) Deferred tax liabilities (Net)

10.039

3.676

0.000

(c) Other long term liabilities

9.945

8.365

10.893

(d) long-term provisions

2.567

1.849

2.032

Total Non-current Liabilities (3)

53.210

66.557

130.169

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

279.440

246.808

216.192

(b) Trade payables

444.147

259.842

149.491

(c) Other current liabilities

52.513

75.538

51.246

(d) Short-term provisions

9.331

4.478

3.605

Total Current Liabilities (4)

785.431

586.666

420.534

 

 

 

 

TOTAL

1111.881

917.606

803.753

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

382.594

377.987

390.766

(ii) Intangible Assets

1.786

0.673

0.000

(iii) Capital work-in-progress

6.969

6.779

30.880

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

3.976

(d)  Long-term Loan and Advances

3.569

9.339

3.291

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

394.918

394.778

428.913

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

203.990

186.517

112.003

(c) Trade receivables

407.197

281.434

186.444

(d) Cash and cash equivalents

24.195

24.676

24.122

(e) Short-term loans and advances

15.873

8.108

5.666

(f) Other current assets

65.708

22.093

46.605

Total Current Assets

716.963

522.828

374.840

 

 

 

 

TOTAL

1111.881

917.606

803.753

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

1764.252

1216.477

775.425

 

Other Income

1.737

1.797

7.340

 

TOTAL (A)

1765.989

1218.274

782.765

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1545.484

1058.405

667.374

 

Purchases of Stock-in-Trade

0.000

6.340

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(36.168)

(69.231)

18.066

 

Employees benefits expense

52.314

36.509

32.626

 

Other expenses

88.836

81.603

77.741

 

TOTAL (B)

1650.466

1113.626

795.807

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

115.523

104.648

(13.042)

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

73.558

66.197

48.500

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

41.965

38.451

(61.542)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

23.663

22.215

19.325

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

18.302

16.236

(80.867)

 

 

 

 

 

Less

TAX (H)

9.445

7.652

(23.926)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)   (I)

8.857

8.584

(56.941)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

595.571

175.400

40.397

 

TOTAL EARNINGS

595.571

175.400

40.397

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

19.78

19.17

(163.32)

 

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approxiamtely)

 

 

2340.000

 

 

 

(Increase in business activity)

 

 

Expected Sales ( 2015-2016) : Rs. 2000.000 Million

 

The above information has been parted by Mr. Kamal (Account Executive)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

41.685

49.216

18.050

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

NA

112.755

(33.400)

Net cash flow from operating activity

NA

112.755

(33.400)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

0.50

0.71

(7.34)

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

6.55

8.60

(1.68)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.66

1.78

(10.52)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.07

0.06

(0.32)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.29

1.32

1.39

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.91

0.89

0.89

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

44.780

44.780

44.780

Reserves & Surplus

208.270

219.603

228.460

Share Application money pending allotment

0.000

0.000

0.000

Net worth

253.050

264.383

273.240

 

 

 

 

long-term borrowings

117.244

52.667

30.659

Short term borrowings

216.192

246.808

279.440

Current Maturities of Long Term Debt

18.050

49.216

41.685

Total borrowings

351.486

348.691

351.784

Debt/Equity ratio

1.389

1.319

1.287

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

775.425

1216.477

1764.252

 

 

56.879

45.030

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

775.425

1216.477

1764.252

Profit

(56.941)

8.584

8.857

 

(7.34%)

0.71%

0.50%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

FINANCIAL HIGHLIGHTS:

 

The Turnover of the Company increased to Rs. 1764.200 Million, during the financial year ended on 31st March, 2014, as compared to last turnover of Rs. 1216.400 Million, thereby registering a growth of 45% as compared to last year

 

The Profit before tax (PBT) stood at Rs. 18.300 Million, for the current financial year, as compared to a profit of Rs. 16.200 Million in the last financial year, thereby registering a growth of 13% as compared to last year.

 

The Profit after tax (PAT) is Rs. 885.700 Million, in the current financial year as compared to profit of Rs. 858.400 Million in the last financial year.

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

LONG TERM BORROWINGS

 

 

Loans and advances from directors

5.204

0.004

 

 

 

SHORT TERM BORROWINGS

 

 

Loans and advances from directors

0.000

22.798

Total

5.204

22.802

 

 

INDEX OF CHARGES

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10299543

01/06/2013 *

98,200,000.00

ORIENTAL BANK OF COMMERCE

HARSHA BHAWAN, E-BLOCK, CONNAUGHT PLACE, NEW DELHI, DELHI - 110001, INDIA

B80144157

2

10274373

21/03/2011

250,000,000.00

UNION BANK OF INDIA

SME BRANCH, 173-174 DSIDC , OKHLA INDUSTRIAL AREA PHASE-I, NEW DELHI, DELHI - 110020, INDIA

B08823544

3

10241193

01/06/2013 *

132,700,000.00

ORIENTAL BANK OF COMMERCE

HARSHA BHAWAN, E-BLOCK, CONNAUGHT PLACE, NEW DELHI, DELHI - 110001, INDIA

B80182876

4

10218856

01/06/2013 *

50,300,000.00

ORIENTAL BANK OF COMMERCE

HARSHA BHAWAN, E-BLOCK, CONNAUGHT PLACE, NEW DELHI, DELHI - 110001, INDIA

B80143563

5

10172622

01/06/2013 *

405,000,000.00

ORIENTAL BANK OF COMMERCE

HARSHA BHAWAN, E-BLOCK, CONNAUGHT PLACE, NEW DELHI, DELHI - 110001, INDIA

B80184807

* Date of charge modification

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 66.55

UK Pound

1

Rs. 100.67

Euro

1

Rs. 70.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUP

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SUD

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

-

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

New Business

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.